208 related articles for article (PubMed ID: 26282471)
1. Gene Expression Signatures as Biomarkers of Tumour Hypoxia.
Harris BH; Barberis A; West CM; Buffa FM
Clin Oncol (R Coll Radiol); 2015 Oct; 27(10):547-60. PubMed ID: 26282471
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia gene expression signatures as predictive biomarkers for personalising radiotherapy.
Yang L; West CM
Br J Radiol; 2019 Jan; 92(1093):20180036. PubMed ID: 29513038
[TBL] [Abstract][Full Text] [Related]
3. Lost in application: Measuring hypoxia for radiotherapy optimisation.
Thiruthaneeswaran N; Bibby BAS; Yang L; Hoskin PJ; Bristow RG; Choudhury A; West C
Eur J Cancer; 2021 May; 148():260-276. PubMed ID: 33756422
[TBL] [Abstract][Full Text] [Related]
4. Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.
Haider S; McIntyre A; van Stiphout RG; Winchester LM; Wigfield S; Harris AL; Buffa FM
Genome Biol; 2016 Jun; 17(1):140. PubMed ID: 27358048
[TBL] [Abstract][Full Text] [Related]
5. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
[TBL] [Abstract][Full Text] [Related]
6. Impact of supervised gene signatures of early hypoxia on patient survival.
Seigneuric R; Starmans MH; Fung G; Krishnapuram B; Nuyten DS; van Erk A; Magagnin MG; Rouschop KM; Krishnan S; Rao RB; Evelo CT; Begg AC; Wouters BG; Lambin P
Radiother Oncol; 2007 Jun; 83(3):374-82. PubMed ID: 17532074
[TBL] [Abstract][Full Text] [Related]
7.
Manem VS; Dhawan A
Br J Radiol; 2019 Nov; 92(1103):20190198. PubMed ID: 31538514
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer.
Starmans MH; Chu KC; Haider S; Nguyen F; Seigneuric R; Magagnin MG; Koritzinsky M; Kasprzyk A; Boutros PC; Wouters BG; Lambin P
Radiother Oncol; 2012 Mar; 102(3):436-43. PubMed ID: 22356756
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy.
Toustrup K; Sørensen BS; Alsner J; Overgaard J
Semin Radiat Oncol; 2012 Apr; 22(2):119-27. PubMed ID: 22385919
[TBL] [Abstract][Full Text] [Related]
10. Divergent mutational processes distinguish hypoxic and normoxic tumours.
Bhandari V; Li CH; Bristow RG; Boutros PC;
Nat Commun; 2020 Feb; 11(1):737. PubMed ID: 32024819
[TBL] [Abstract][Full Text] [Related]
11. Role of MicroRNA in Hypoxic Tumours and their Potential as Biomarkers for Early Detection of Cancer.
Jayashree P; Kalpita M; Judith T; Singh AS; Ashwin K
Curr Mol Med; 2024; 24(5):525-536. PubMed ID: 38310548
[TBL] [Abstract][Full Text] [Related]
12. Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
Jubb AM; Buffa FM; Harris AL
J Cell Mol Med; 2010 Jan; 14(1-2):18-29. PubMed ID: 19840191
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cells.
Leithner K; Wohlkoenig C; Stacher E; Lindenmann J; Hofmann NA; Gallé B; Guelly C; Quehenberger F; Stiegler P; Smolle-Jüttner FM; Philipsen S; Popper HH; Hrzenjak A; Olschewski A; Olschewski H
BMC Cancer; 2014 Jan; 14():40. PubMed ID: 24460801
[TBL] [Abstract][Full Text] [Related]
14. Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity.
Fjeldbo CS; Hompland T; Hillestad T; Aarnes EK; Günther CC; Kristensen GB; Malinen E; Lyng H
EBioMedicine; 2020 Jul; 57():102841. PubMed ID: 32580139
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis of hypoxic cancer cells uncovers intron retention in EIF2B5 as a mechanism to inhibit translation.
Brady LK; Wang H; Radens CM; Bi Y; Radovich M; Maity A; Ivan C; Ivan M; Barash Y; Koumenis C
PLoS Biol; 2017 Sep; 15(9):e2002623. PubMed ID: 28961236
[TBL] [Abstract][Full Text] [Related]
16. In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.
Abu-Jamous B; Buffa FM; Harris AL; Nandi AK
Mol Cancer; 2017 Jun; 16(1):105. PubMed ID: 28619028
[TBL] [Abstract][Full Text] [Related]
17. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours.
Bigos KJ; Quiles CG; Lunj S; Smith DJ; Krause M; Troost EG; West CM; Hoskin P; Choudhury A
Front Oncol; 2024; 14():1331355. PubMed ID: 38352889
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
[TBL] [Abstract][Full Text] [Related]
19. Interplay of long non-coding RNAs and HIF-1α: A new dimension to understanding hypoxia-regulated tumor growth and metastasis.
Wang X; Zhao D; Xie H; Hu Y
Cancer Lett; 2021 Feb; 499():49-59. PubMed ID: 33217445
[TBL] [Abstract][Full Text] [Related]
20. The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines.
Fardin P; Barla A; Mosci S; Rosasco L; Verri A; Varesio L
BMC Genomics; 2009 Oct; 10():474. PubMed ID: 19832978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
